Atomized Inhalation ICG for Treatment of Congenital Lung Malformations
To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.
| Condition(s) | Pulmonary Sequestration, Congenital Pulmonary Airway Malformation, Indocyanine Green, Thoracoscopic Surgery, Children |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children. |
| Who can participate | Inclusion Criteria: * children with congenital lung malformations diagnosed by CT or MRI scan Exclusion Criteria: * 1\. ages \<3 months and \>14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection |
| Ages | 3 Months to 14 Years |
| Sex | All |
| Lead sponsor | Jiexiong Feng |
| Locations | Wuhan, Hubei, China |
| Start date | 2024-03-01 |
| NCT ID | NCT06302985 |
| Official listing | https://clinicaltrials.gov/study/NCT06302985 |